Key Highlights
● First-half 2026 Revenue was $342,634, up about 110%.
● Gross Margin improved to roughly 59.5% from about 48.0%.
● The net loss narrowed slightly to $402,511.
● The BRLIT Dental Laboratory Acquisition closed on May 6, 2026.
Standard Dental Labs Inc. (OTC:TUTH), a small dental laboratory company pursuing growth through acquisitions, more than doubled revenue in the first half of 2026. Its semiannual report, filed with the SEC on Sept. 29 under Regulation A, also disclosed that the company's financial condition raises substantial doubt about its ability to continue as a going concern. For a Business funding a roll-up strategy, the Balance Sheet and access to Capital may be as important as revenue growth in assessing its prospects. The company's shares are quoted on the OTCQB, according to the filing.
Latest Company Context
According to the Form 1-SA, revenue for the six months ended June 30, 2026, was $342,634, up about 110% from $163,261 a year earlier. Gross Profit rose to $203,718 from $78,414, implying a gross margin of roughly 59.5% versus about 48.0%. Operating expenses increased to $522,303, and the net loss narrowed slightly to $402,511, or $0.011 per share, from $424,347. The company closed its acquisition of BRLIT Dental Laboratory in Florida on May 6, 2026, for total consideration of $900,000, consisting of $300,000 in cash, half deferred for 180 days subject to a revenue condition, and 1.2 million restricted shares valued at $600,000. It also entered an asset purchase agreement for Sheen Dental Laboratory in Dunedin, Florida, in December 2025. Cost of Goods Sold rose to $138,916 from $84,847.
Key Business and index Drivers
At June 30, 2026, Standard Dental Labs reported cash of $13,169 and total current Assets of $297,752, against total liabilities of $4.35 million. Liabilities included $1.97 million of convertible notes, a $1.17 million convertible note held by Shareholder James D. Brooks, and $266,818 of accrued interest. The balance sheet showed a stockholders' Deficit of about $3.14 million. Management said it plans to raise capital through its Regulation A offering and other financings, integrate acquired operations and improve results.
Because much of the Debt is convertible, future conversions could reduce cash obligations but increase the share count; weighted-average shares already rose to about 37.3 million from 30.6 million. The filing also noted that revenue since the BRLIT closing has averaged below the 80% threshold tied to deferred consideration, which could affect the final payment.
What Investors Should Watch
Investors may watch for capital raised under the company's qualified Tier 2 Regulation A offering, as well as any new financing that could address the Working Capital deficit of roughly $4.06 million reported in the filing. Updates on the Sheen Dental and other announced lab agreements, including closing status and terms, may indicate the pace of the acquisition strategy. Management expects revenue and Volume to keep growing through the rest of 2026. The Annual Report on Form 1-K for 2026 would ordinarily be due in the spring of 2027 under Regulation A rules; the company filed its 2025 annual report on April 9, 2026. Any current reports on Form 1-U may disclose material developments in the interim. Integration of the BRLIT laboratory and its revenue performance against the earn-out threshold may also be monitored.
Rapid Growth From a Very Small Base
Standard Dental Labs shows rapid percentage revenue growth from a very small base, supported by acquisitions and improving gross margins. Its going-concern disclosure, minimal cash and substantial convertible debt mean that funding remains a central uncertainty. Future financings, conversion activity and acquisition closings may determine how the company's Capital Structure evolves. As a very small issuer with limited liquidity, the company's progress may depend heavily on its ability to secure new capital on acceptable terms. Improvements in gross margin suggest some operating progress, but the scale of liabilities relative to revenue remains significant.


_11_18_2026_14_40_45_405856.jpg)



Please wait processing your request...